DCM
BLCM

Driehaus Capital Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Driehaus Capital Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-8,764
Closed -$1.86M – 638
2015
Q2 		$1.86M Buy
+8,764
New +$2.15M 0.06% 346

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Driehaus Capital Management's BLCM Position: Q3 2015 in Review

Driehaus Capital Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2015, closing a stake of 8,764 shares — an estimated $1.86M sold.

Driehaus Capital Management first reported a position in BLCM in Q2 2015 and held it in 1 quarter. The position peaked at $1.86M in Q2 2015. 83 funds tracked by Wall St. Rank hold BLCM as of Q3 2015.

  • Driehaus Capital Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Driehaus Capital Management sold 8,764 Bellicum Pharmaceuticals, Inc. shares in Q3 2015, an estimated $1.86M.
  • Driehaus Capital Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2015 and held it in 1 quarter.
  • Driehaus Capital Management's Bellicum Pharmaceuticals, Inc. position peaked at $1.86M in Q2 2015.
  • 83 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2015.

Based on Driehaus Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.